Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/1939
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | - |
dc.contributor.author | OLIVEIRA, C. P. M. S. | - |
dc.contributor.author | KAPPEL, C. R. | - |
dc.contributor.author | SIQUEIRA, E. R. | - |
dc.contributor.author | LIMA, V. M. R. | - |
dc.contributor.author | STEFANO, J. T. | - |
dc.contributor.author | MICHALCZUK, M. T. | - |
dc.contributor.author | MARINI, S. S. | - |
dc.contributor.author | BARBEIRO, H. V. | - |
dc.contributor.author | SORIANO, F. G. | - |
dc.contributor.author | CARRILHO, F. J. | - |
dc.contributor.author | PEREIRA, L. M. M. B. | - |
dc.contributor.author | ALVARES-DA-SILVA, M. R. | - |
dc.date.accessioned | 2013-09-23T16:39:10Z | - |
dc.date.available | 2013-09-23T16:39:10Z | - |
dc.date.issued | 2013 | - |
dc.identifier.citation | INTERNATIONAL JOURNAL OF CARDIOLOGY, v.164, n.2, p.221-226, 2013 | - |
dc.identifier.issn | 0167-5273 | - |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/1939 | - |
dc.description.abstract | The role of hepatitis C virus (HCV) in the pathogenesis of atherosclerosis and cardiovascular events is unclear. The aim of this study was to evaluate the direct effect of HCV on cardiovascular risk and correlate it with pro and anti-inflammatory cytokines in patients with HCV. HCV monoinfected patients, genotype 1, naive, non-obese (BMI<30) and non-diabetics were included and compared to controls (blood donors). Patients with prior diagnosis of cardiovascular diseases, hypertension, chronic renal failure, cancer and chronic use of lipid-lowering drugs or immunosuppressants were excluded. Age, BMI, systolic blood pressure (SBP) and diastolic (DBP), fasting glucose and lipid levels were determined. Serum cytokines (IL-6, IL-10 and TNF-alpha) and Framingham score were also evaluated. 62 HCV patients, 34 (54.8%) were males and none of them was smoking. The Framingham scores (median and 25th and 75th percentiles) were 12% (6.5-14%), showing an intermediate cardiovascular risk in patients with HCV. There was significant direct correlation between Framingham and total cholesterol (p=0.043) and DBP (p=0.007). HDL-C (p=0.002) was inversely correlated with the Framingham score. HCV patients had higher levels of proinflammatory cytokines (IL-6 and TNF-alpha) compared to controls (p<0.0001) and the relation of proinflammatory/anti-inflammatory TNF-alpha/IL10 and IL-6/IL10 were higher in HCV patients (p<0.01). The Framingham score was directly correlated to IL-6 and TNF-alpha, but differences were not statistically significant. Patients with HCV monoinfected, nonobese, naive and non diabetic have an intermediate cardiovascular risk, as measured by the Framingham score and high levels of proinflammatory cytokines (IL-6 and TNF). | - |
dc.language.iso | eng | - |
dc.publisher | ELSEVIER IRELAND LTD | - |
dc.relation.ispartof | International Journal of Cardiology | - |
dc.rights | restrictedAccess | - |
dc.subject | Hepatitis C virus | - |
dc.subject | Cardiovascular risk | - |
dc.subject | Framingham Score | - |
dc.subject | Pro-inflammatory cytokines | - |
dc.subject.other | insulin-resistance | - |
dc.subject.other | cells | - |
dc.subject.other | atherosclerosis | - |
dc.subject.other | association | - |
dc.subject.other | expression | - |
dc.subject.other | steatosis | - |
dc.subject.other | disease | - |
dc.subject.other | interleukin-10 | - |
dc.subject.other | seropositivity | - |
dc.subject.other | cholesterol | - |
dc.title | Effects of Hepatitis C virus on cardiovascular risk in infected patients: A comparative study | - |
dc.type | article | - |
dc.rights.holder | Copyright ELSEVIER IRELAND LTD | - |
dc.identifier.doi | 10.1016/j.ijcard.2011.07.016 | - |
dc.identifier.pmid | 21784542 | - |
dc.subject.wos | Cardiac & Cardiovascular Systems | - |
dc.type.category | original article | - |
dc.type.version | publishedVersion | - |
hcfmusp.author.external | KAPPEL, C. R.:Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Sch Med, Div Gastroenterol, Porto Alegre, RS, Brazil | - |
hcfmusp.author.external | SIQUEIRA, E. R.:Liver Inst Pernambuco, Recife, PE, Brazil | - |
hcfmusp.author.external | MICHALCZUK, M. T.:Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Sch Med, Div Gastroenterol, Porto Alegre, RS, Brazil | - |
hcfmusp.author.external | MARINI, S. S.:Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Sch Med, Div Gastroenterol, Porto Alegre, RS, Brazil | - |
hcfmusp.author.external | PEREIRA, L. M. M. B.:Liver Inst Pernambuco, Recife, PE, Brazil | - |
hcfmusp.author.external | ALVARES-DA-SILVA, M. R.:Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Sch Med, Div Gastroenterol, Porto Alegre, RS, Brazil | - |
hcfmusp.description.beginpage | 221 | - |
hcfmusp.description.endpage | 226 | - |
hcfmusp.description.issue | 2 | - |
hcfmusp.description.volume | 164 | - |
hcfmusp.origem | WOS | - |
hcfmusp.origem.id | 2-s2.0-84875217762 | - |
hcfmusp.origem.id | WOS:000316599200018 | - |
hcfmusp.publisher.city | CLARE | - |
hcfmusp.publisher.country | IRELAND | - |
hcfmusp.relation.reference | Abbas Z, 2003, J Pak Med Assoc, V53, P59 | - |
hcfmusp.relation.reference | ALTER MJ, 1995, SEMIN LIVER DIS, V15, P5, DOI 10.1055/s-2007-1007259 | - |
hcfmusp.relation.reference | ANDERSON C, 1991, NATURE, V353, P289 | - |
hcfmusp.relation.reference | ANDERSON KM, 1991, CIRCULATION, V83, P356 | - |
hcfmusp.relation.reference | Armstrong GL, 2006, ANN INTERN MED, V144, P705 | - |
hcfmusp.relation.reference | Boddi Maria, 2007, Dig Liver Dis, V39 Suppl 1, pS55, DOI 10.1016/S1590-8658(07)80012-0 | - |
hcfmusp.relation.reference | Brown PMJ, 2001, CLIN BIOCHEM, V34, P167, DOI 10.1016/S0009-9120(01)00210-7 | - |
hcfmusp.relation.reference | Chen Y, 2007, AM J PHYSIOL-RENAL, V293, P680 | - |
hcfmusp.relation.reference | Clement S, 2009, VIRUSES-BASEL, V1, P126, DOI 10.3390/v1020126 | - |
hcfmusp.relation.reference | Corey KE, 2009, HEPATOLOGY, V50, P1030, DOI 10.1002/hep.23219 | - |
hcfmusp.relation.reference | Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1 | - |
hcfmusp.relation.reference | de Waal MR, 1991, J EXP MED, V174, P915, DOI 10.1084/JEM.174.4.915 | - |
hcfmusp.relation.reference | de Waal M.R., 1991, J EXP MED, V174, P1209 | - |
hcfmusp.relation.reference | Fartoux L, 2005, GUT, V54, P1003, DOI 10.1136/gut.2004.050302 | - |
hcfmusp.relation.reference | Fernandez-Real JM, 1999, DIABETOLOGIA, V42, P1367, DOI 10.1007/s001250051451 | - |
hcfmusp.relation.reference | FIORENTINO DF, 1991, J IMMUNOL, V146, P3444 | - |
hcfmusp.relation.reference | Floris-Moore M, 2007, AIDS PATIENT CARE ST, V21, P479, DOI 10.1089/apc.2006.0150 | - |
hcfmusp.relation.reference | Freiberg MS, 2007, AIDS, V21, P193, DOI 10.1097/QAD.0b013e3280118a0d | - |
hcfmusp.relation.reference | Fukui M, 2003, JAMA-J AM MED ASSOC, V289, P1245, DOI 10.1001/jama.289.10.1245-b | - |
hcfmusp.relation.reference | Gruady SM, 2004, CIRCULATION, V109, P551 | - |
hcfmusp.relation.reference | Guiltinan AM, 2008, AM J EPIDEMIOL, V167, P743, DOI 10.1093/aje/kwm370 | - |
hcfmusp.relation.reference | Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220 | - |
hcfmusp.relation.reference | Ishizaka N, 2002, LANCET, V359, P133, DOI 10.1016/S0140-6736(02)07339-7 | - |
hcfmusp.relation.reference | Lecube A, 2006, DIABETES CARE, V29, P1096, DOI 10.2337/dc05-2509 | - |
hcfmusp.relation.reference | Llorente L, 1996, J HEPATOL, V24, P555, DOI 10.1016/S0168-8278(96)80140-1 | - |
hcfmusp.relation.reference | Maggi G, 1996, ITAL J GASTROENTEROL, V28, P436 | - |
hcfmusp.relation.reference | Marzouk D, 2007, GUT, V56, P1105, DOI 10.1136/gut.2006.091983 | - |
hcfmusp.relation.reference | Milner KL, 2010, GASTROENTEROLOGY, V138, P932, DOI 10.1053/j.gastro.2009.11.050 | - |
hcfmusp.relation.reference | Mostafa A, 2010, GUT, V59, P1135, DOI 10.1136/gut.2009.202317 | - |
hcfmusp.relation.reference | Negro F, 2009, J VIRAL HEPATITIS, V16, P681, DOI 10.1111/j.1365-2893.2009.01186.x | - |
hcfmusp.relation.reference | Persico M, 2007, HEPATOLOGY, V46, P1009, DOI 10.1002/hep.21782 | - |
hcfmusp.relation.reference | Ruan XZ, 2003, J AM SOC NEPHROL, V14, P593, DOI 10.1097/01.ASN.0000050414.52908.DA | - |
hcfmusp.relation.reference | Syed GH, 2009, TRENDS ENDOCRIN MET, V21, P33 | - |
hcfmusp.relation.reference | Tsui JI, 2009, J CARD FAIL, V15, P451, DOI [10.1016/j.cardfail.2008.12.003, 10.1016/j.cardfail.2009.12.003] | - |
hcfmusp.relation.reference | Tsuruma T, 1998, CELL IMMUNOL, V184, P121, DOI 10.1006/cimm.1998.1266 | - |
hcfmusp.relation.reference | Vassalle C, 2004, HEART, V90, P565, DOI 10.1136/hrt.2003.018937 | - |
hcfmusp.relation.reference | Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545 | - |
hcfmusp.relation.reference | Yue FY, 1997, INT J CANCER, V71, P630, DOI 10.1002/(SICI)1097-0215(19970516)71:4<630::AID-IJC20>3.0.CO;2-E | - |
hcfmusp.relation.reference | Zeller JC, 1999, J IMMUNOL, V163, P3684 | - |
dc.description.index | MEDLINE | - |
hcfmusp.citation.scopus | 72 | - |
hcfmusp.scopus.lastupdate | 2024-03-08 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MCM Artigos e Materiais de Revistas Científicas - FM/MGT Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - LIM/07 Artigos e Materiais de Revistas Científicas - LIM/51 Artigos e Materiais de Revistas Científicas - ODS/03 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_OLIVEIRA_Effects_of_Hepatitis_C_virus_on_cardiovascular_risk_2013.PDF Restricted Access | publishedVersion (English) | 605.97 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.